Table of Contents

In vitro evaluation of metabolic drug-drug interactions: concepts and practice / Albert P. Li.
In vitro approaches to anticipating clinical drug interactions / Laurie P. Volak, David J. Greenblatt, Lisa L. von Moltke.
Inhibition of drug metabolizing enzymes and drug-drug interactions in drug discovery and development / R. Scott Obach.
Mechanism-based CYP inhibition: enzyme kinetics, assays, and prediction of human drug-drug interactions / Magang Shou.
Genomic approaches to drug-drug interactions / Yi Yang, Jeffrey F. Waring.
Transporters and drug interactions / Yoshihisa Shitara, Toshiharu Horie, and Yuichi Sugiyama.
Transporter-mediated drug interactions: molecular mechanisms and clinical implications / Jiunn H. Lin.
Recent case studies of clinically significant drug-drug interactions and the limits of in vitro prediction methodology / R.H. Levy, I. Ragueneau-Majlessi, C. Collins.
US regulatory perspective: drug-drug interactions / John Strong and Shiew-Mei Huang.
Herbal drug interactions: a Canadian perspective / Brian C. Foster. Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage.